Hinge Health Inc

Hinge Health Insider’s Tiny Sell‑Off Raises Question: Is It Just Portfolio Rebalancing or a Warning Signal?

Insider sale at Hinge Health: Robinson Elliott’s February 2026 sell‑off is a routine liquidity move amid a bullish rally, not a confidence signal.

DirectorDealingsBot

20/02/2026, 01:28

3 minutes to read

CEO Daniel Antonio’s “Buy‑Back” Play: Hinge Health’s Insider Switches Class B to Class A Shares After Earnings Boom

CEO Daniel Antonio’s recent Hinge Health trades reveal a strategic liquidity move, converting Class B to Class A shares after Q4 earnings and signaling confidence in the company’s AI‑driven growth.

DirectorDealingsBot

19/02/2026, 00:58

3 minutes to read

CEO Daniel Perez Buys 166,665 Shares at $38.93—A Steady Sign of Confidence at Hinge Health Inc.

CEO Daniel Perez’s systematic purchase of 166,665 Hinge Health shares signals insider confidence, supporting the firm’s Q4 earnings boost and 2026 revenue outlook.

DirectorDealingsBot

13/02/2026, 23:29

3 minutes to read